Drugs & Targets WVU gets FDA approval for clinical trial of drug to treat eye cancer ‘from the inside out’ November 19, 2021Vol.47 No.43
Drugs & Targets Ribonexus, Pierre Fabre sign licensing agreement on small molecules targeting eIF4A November 19, 2021Vol.47 No.43
Drugs & Targets FDA’s new web pages track accelerated approvals in oncology October 29, 2021Vol.47 No.40
Drugs & Targets Kymriah granted FDA priority review and EMA filing acceptance October 29, 2021Vol.47 No.40
Drugs & Targets Morphogenesis receives FDA ‘fast track’ designation for skin cancer vaccine October 29, 2021Vol.47 No.40
Drugs & Targets Foundation Medicine now an in-network provider for Humana Military and Health Net Federal Services October 29, 2021Vol.47 No.40
Drugs & Targets Citius acquires license for late-phase III oncology immunotherapy for cutaneous T-cell lymphoma October 29, 2021Vol.47 No.40
Drugs & Targets Cardinal Health receives $750,000 FDA grant to study oncology trial designs by comparing RWE to RCT results October 29, 2021Vol.47 No.40
